Your browser doesn't support javascript.
loading
Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions.
Mereu, Maddalena; Hiranita, Takato; Jordan, Chloe J; Chun, Lauren E; Lopez, Jessica P; Coggiano, Mark A; Quarterman, Juliana C; Bi, Guo-Hua; Keighron, Jacqueline D; Xi, Zheng-Xiong; Newman, Amy Hauck; Katz, Jonathan L; Tanda, Gianluigi.
Afiliación
  • Mereu M; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Hiranita T; Psychobiology Section, Molecular Neuropsychiatry Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Jordan CJ; Department of Pharmacodynamics, College of Pharmacy, University of Florida, 1345 Center Drive, Gainesville, FL, 32610, USA.
  • Chun LE; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Lopez JP; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Coggiano MA; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Quarterman JC; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Bi GH; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Keighron JD; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Xi ZX; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Newman AH; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Katz JL; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
  • Tanda G; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 251 Bayview Blvd., NIDA suite 200, Baltimore, MD, 21224, USA.
Neuropsychopharmacology ; 45(9): 1518-1526, 2020 08.
Article en En | MEDLINE | ID: mdl-32340023
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cocaína / Estimulantes del Sistema Nervioso Central / Metilfenidato Límite: Animals Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cocaína / Estimulantes del Sistema Nervioso Central / Metilfenidato Límite: Animals Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos